Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules
- Published
- 15 Apr 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Superpotent and Subpotent
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack).
- Brand / company
- Teva Pharmaceuticals USA, Inc
- Codes / lots
- Lots 100075305 Exp date 06/2027, 100075512, Exp date 07/2027 & 100076103, Exp date 07/2027 . | Lots 100055426, Exp. date 02/2026, 100071518, Exp. date 04/2027 & 100072450, Exp. Date 07/2027
- Distribution
- FL, OH, PR & MS
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 15 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.